Our approach reveals that DGAT1 expression specifically in the hematopoietic compartment limits the inflammatory impact of WTD consumption on vascular plaques in the context of LDL receptor deficiency while having little if any effect on atherosclerosis per se or on other structural determinants of plaque composition. The gene discussed is DGAT1; the disease is atherosclerosis.